Global Oral Thrush Market Growth (Status and Outlook) 2023-2029

Global Oral Thrush Market Growth (Status and Outlook) 2023-2029

Oral thrush occurs when a yeast infection develops on the inside of mouth and on tongue. This condition is also known as oral candidiasis, oropharyngeal candidiasis, or, simply, thrush. The Candida albicans fungus causes oral thrush. A small amount of this fungus normally lives in your mouth without causing harm. However, when the fungus begins to grow uncontrollably, an infection can develop in mouth. Oral thrush most often occurs in infants and toddlers. It causes white bumps to form on the inner cheeks and tongue. These growths usually go away once treatment is received.

LPI (LP Information)' newest research report, the “Oral Thrush Industry Forecast” looks at past sales and reviews total world Oral Thrush sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Thrush sales for 2023 through 2029. With Oral Thrush sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Thrush industry.

This Insight Report provides a comprehensive analysis of the global Oral Thrush landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Thrush portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Thrush market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Thrush and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Thrush.

The global Oral Thrush market size is projected to grow from US$ 7042.5 million in 2022 to US$ 8424.8 million in 2029; it is expected to grow at a CAGR of 2.6% from 2023 to 2029.

Treatment for oral thrush varies depending on age and overall health. The purpose of treatment is to prevent the growth and spread of the fungus. Once treatment begins, oral thrush usually goes away within a couple of weeks. However, oral thrush may return again in the future. A complete cure is more likely if patients have a healthy immune system and are free of other diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Thrush market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Pseudomembranous
Erythematous
Hyperplastic

Segmentation by application
Hospitals & Clinics
Academic And Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
Teva Pharmaceuticals
Stellar Pharma
Pfizer
Wockhardt
Ranbaxy Laboratories
Bristol Laboratories
Glenmark Pharmaceuticals
GlaxoSmithKline

Please note: The report will take approximately 2 business days to prepare and deliver.